Lilly, Vertex top pharma performers in H1; Moderna, Pfizer the worst

iQoncept

Buoyed by booming diabetes drug sales, Eli Lilly (New York Stock Exchange: LLY) was the best performer in big pharma or biotech in the first half of 2023, returning dazzling 28%.

Coming in at number two, Vertex Pharmaceuticals (VRTX), is buoyed by continued strong revenue from cystic

LillyModernaperformersPfizerPharmaTopVertexWorst
Comments (0)
Add Comment